Dihydroergotamine Mesylate
NDC 68083-466, Dihydroergotamine Mesylate, injection, from Gland Pharma Limited.
- Product NDC
- 68083-466
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215623
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-466 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIHYDROERGOTAMINE MESYLATE1 mg/mL
Pharmacologic classes
Ergotamine Derivative [EPC]; Ergotamines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-466-10 | 68083046610 | 10 AMPULE in 1 CARTON (68083-466-10) / 1 mL in 1 AMPULE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/07a9112c-8c04-4849-8cb3-9463f58731d2
Use it
Look up 68083-466 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-466 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-466. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.